Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06244290 · ClinicalTrials.gov registry record · Phase 3
Dentinal Hypersensitivity Reduction
A Phase 3 study, sponsored by Colgate Palmolive.
- Completed
- Registry status
- Phase 3
- Development phase
- 123
- Enrollment target
NCT06244290 is a Phase 3 study that has completed, run by Colgate Palmolive. The registered enrollment target is 123 participants.
The verdict
NCT06244290, a Phase 3 study, has completed, sponsored by Colgate Palmolive.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 123 participants
- Enrollment target
Study Summary
The objective of this clinical study is to assess the efficacy of a dentifrice containing stannous fluoride (Colgate-Palmolive Company, New York, NY, USA) as compared to a commercially-available potassium-based toothpaste (Sensodyne Extra Whitening Toothpaste, GlaxoSmithKline Co., UK) and a commercially available non-desensitizing toothpaste (Colgate Cavity Protection Toothpaste, Colgate-Palmolive Company, New York, NY, USA) in the reduction of dentinal hypersensitivity over a seven (7) day period.
Interventions
- DRUG Colgate SNF
- DRUG Sensodyne Extra Whitening
- DRUG Colgate Fluoride (CDC)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 123 participants |
| Start Date | 2020-09-28 |
| Est. Completion | 2020-10-21 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06244290
The ClinicalTrials.gov registry entry for NCT06244290 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 123 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Colgate Palmolive, which has 51 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Colgate SNF is the first listed.
NCT06244290 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06244290 about?
NCT06244290 is a clinical study titled "Dentinal Hypersensitivity Reduction". The objective of this clinical study is to assess the efficacy of a dentifrice containing stannous fluoride (Colgate-Palmolive Company, New York, NY, USA) as compared to a commercially-available potassium-based toothpaste (Sensodyne Extra Whitening Toothpaste, GlaxoSmithKline Co., UK) and a commerci...
What is the current status of trial NCT06244290?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 123 participants. The study started on 2020-09-28. Estimated completion is 2020-10-21.
What interventions are being tested in trial NCT06244290?
The interventions under investigation include: Colgate SNF (DRUG), Sensodyne Extra Whitening (DRUG), Colgate Fluoride (CDC) (DRUG).
Who is sponsoring clinical trial NCT06244290?
This trial is sponsored by Colgate Palmolive, which has 51 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.